Literature DB >> 16087923

Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine.

B H Ridha1, K A Josephs, M N Rossor.   

Abstract

Three patients with probable dementia with Lewy bodies (DLB) experienced worsening delusions and visual hallucinations as a result of memantine therapy. Significant resolution occurred once treatment was discontinued. Caution is required when prescribing memantine to patients with possible DLB.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16087923     DOI： 10.1212/01.wnl.0000172351.95783.8e

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  19 in total

Review 1.  Homeostatic disinhibition in the aging brain and Alzheimer's disease.

Authors:  Marc Gleichmann; Vivian W Chow; Mark P Mattson
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

2.  Donepezil markedly potentiates memantine neurotoxicity in the adult rat brain.

Authors:  Catherine E Creeley; David F Wozniak; Anthony Nardi; Nuri B Farber; John W Olney
Journal:  Neurobiol Aging       Date:  2006-11-16       Impact factor: 4.673

3.  Visual hallucinations and agitation in Alzheimer's disease due to memantine: report of three cases.

Authors:  Roberto Monastero; Cecilia Camarda; Carmela Pipia; Rosolino Camarda
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10-09       Impact factor: 10.154

4.  Advances in the treatment of visual hallucinations in neurodegenerative diseases.

Authors:  Daniel Collerton; John-Paul Taylor
Journal:  Future Neurol       Date:  2013-07

Review 5.  Alternatives to atypical antipsychotics for the management of dementia-related agitation.

Authors:  Michael J Passmore; David M Gardner; Yvette Polak; Kiran Rabheru
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 6.  Management of Parkinson's disease dementia : practical considerations.

Authors:  Arvid Rongve; Dag Aarsland
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

7.  Efficacy and safety of memantine in Lewy body dementia.

Authors:  O S Levin; L A Batukaeva; I G Smolentseva; N A Amosova
Journal:  Neurosci Behav Physiol       Date:  2009-07

Review 8.  Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease.

Authors:  Nathan Herrmann; Serge Gauthier
Journal:  CMAJ       Date:  2008-12-02       Impact factor: 8.262

Review 9.  Biochemical and pathological correlates of cognitive and behavioural change in DLB/PDD.

Authors:  Paul T Francis
Journal:  J Neurol       Date:  2009-08       Impact factor: 4.849

Review 10.  Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias.

Authors:  Stuart J Thomas; George T Grossberg
Journal:  Clin Interv Aging       Date:  2009-10-12       Impact factor: 4.458
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.